Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.
Tezpur University researchers discover blood markers for early gallbladder cancer detection, promising timely diagnosis and ...
Zanidatamab plus chemotherapy delays progression or death in patients with untreated locally advanced or metastatic gastroesophageal adenocarcinoma.
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
New research from University of Lucknow and King George’s Medical University shows that specific protein markers involved in ...
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...
Sportschosun on MSN
Professor Kim Kwang-pyo's team at Kyung Hee University develops next-generation anti-cancer technolo...
A research team led by Professor Kim Kwang-pyo of Kyung Hee University's Department of Applied Chemistry has developed a next ...
We initiated a historic collective ride led by two cancer survivors Harka Lama and Kabita Chitrakar from Chewa Bhanjyang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results